Literature DB >> 22375994

Bleeding risk with dabigatran in the frail elderly.

Paul Harper, Laura Young, Eileen Merriman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22375994     DOI： 10.1056/NEJMc1112874

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  73 in total

1.  Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients.

Authors:  Syed Mahamad; Hina Chaudhry; Rosane Nisenbaum; Amanda McFarlan; Sandro Rizoli; Alun Ackery; Michelle Sholzberg
Journal:  J Thromb Thrombolysis       Date:  2019-02       Impact factor: 2.300

2.  Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: the need to manage the introduction of new drugs.

Authors:  Amelia Troncoso; Eduard Diogène
Journal:  Eur J Clin Pharmacol       Date:  2013-10-17       Impact factor: 2.953

3.  Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism.

Authors:  Fahri Gunes; Mehmet Asik; Ahmet Temiz; Emine Binnetoglu; Hacer Sen; Ogun İrem Bilen; Erdem Akbal; Gurhan Adam; Kubilay Ukinc
Journal:  Wien Klin Wochenschr       Date:  2013-11-16       Impact factor: 1.704

4.  Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.

Authors:  W Hernandez; E R Gamazon; K Aquino-Michaels; S Patel; T J O'Brien; A F Harralson; R A Kittles; A Barbour; M Tuck; S D McIntosh; J N Douglas; D Nicolae; L H Cavallari; M A Perera
Journal:  Pharmacogenomics J       Date:  2013-09-10       Impact factor: 3.550

Review 5.  Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

Review 6.  [New oral anticoagulants for the prevention of stroke. Open questions in geriatric patients].

Authors:  H K Berthold
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

Review 7.  Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations.

Authors:  Helen Mani; Alexander Kasper; Edelgard Lindhoff-Last
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

8.  Appropriateness of Dabigatran and Rivaroxaban Prescribing for Hospital Inpatients.

Authors:  Unnum Chowdhry; Amanda Jacques; Alan Karovitch; Pierre Giguère; My-Linh Nguyen
Journal:  Can J Hosp Pharm       Date:  2016-06-30

9.  Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.

Authors:  S Casey Laizure; Robert B Parker; Vanessa L Herring; Zhe-Yi Hu
Journal:  Drug Metab Dispos       Date:  2013-11-08       Impact factor: 3.922

10.  The untold story of Dabigatran etexilate: alveolar hemorrhage in an elderly patient with interstitial pulmonary fibrosis.

Authors:  Ahmad Husari; Atallah Beydoun; Amein Sheik Ammar; Joseph E Maakaron; Ali Taher
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.